Your session is about to expire
← Back to Search
Chemotherapy + Radiation for Hodgkin's Lymphoma
Study Summary
This trial is studying a combination of chemotherapy drugs with or without radiation therapy to see how well it treats young patients with a low-risk form of Hodgkin lymphoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer is early stage with limited spread and no extranodal involvement.My cancer is at an advanced stage or has specific high-risk features.If my disease is reassessed as intermediate risk, I will be taken off the HOD08 trial.My Hodgkin lymphoma diagnosis is confirmed and I haven't received any treatment yet.I am 21 years old or younger.
- Group 1: Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA cleared radiation therapy for use?
"Given that this is a Phase 2 trial, meaning that while there is some data supporting safety, none yet supports efficacy, our team has given Radiation Therapy a score of 2."
How many different hospitals are conducting this research?
"There are six principle hospitals conducting this research, for example Children's Hospital of Illinois at OSF St. Francis Medical Center in Peoria, Rady Children's Hospital- San Diego in San Diego, and Packard Children's Hospital, Stanford University in Palo Alto. In addition to those locations, there are also 6 other sites."
Are participants still being recruited for this research?
"This clinical trial is not actively recruiting patients. The last update on the website was on August 9th, 2022. There are 1770 other studies that are active right now."
Share this study with friends
Copy Link
Messenger